These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8803664)

  • 1. The new generation of antipsychotic drugs.
    Tamminga CA; Lahti AC
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():73-6. PubMed ID: 8803664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antipsychotic drugs].
    Weizer M; Levy A; Davidson M
    Harefuah; 1997 Jul; 133(1-2):57-60. PubMed ID: 9332062
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenia, VI: Treatments.
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
    [No Abstract]   [Full Text] [Related]  

  • 4. [New antipsychotic agents].
    Olie JP; Ghaoui S; Bayle FJ
    Encephale; 1999 Nov; 25 Spec No 3():52-60. PubMed ID: 10598295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug metabolism and atypical antipsychotics.
    Prior TI; Chue PS; Tibbo P; Baker GB
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):301-9. PubMed ID: 10422890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antipsychotic use in schizophrenia.
    J Clin Psychiatry; 2000 Mar; 61(3):223-32. PubMed ID: 10841660
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life and new antipsychotics in schizophrenia. Are patients better off?
    Awad AG; Voruganti LN
    Int J Soc Psychiatry; 1999; 45(4):268-75. PubMed ID: 10689610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
    Möller HJ
    Nervenarzt; 2000 May; 71(5):345-53. PubMed ID: 10846709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication and seizures: a review.
    Hedges D; Jeppson K; Whitehead P
    Drugs Today (Barc); 2003 Jul; 39(7):551-7. PubMed ID: 12973403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences among antipsychotics.
    Tamminga CA
    J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone: a new atypical antipsychotic.
    Keck PE; McElroy SL; Arnold LM
    Expert Opin Pharmacother; 2001 Jun; 2(6):1033-42. PubMed ID: 11585006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of schizophrenia.
    Kane JM
    Biol Psychiatry; 1999 Nov; 46(10):1396-408. PubMed ID: 10578454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
    Revicki DA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):110-7. PubMed ID: 11527002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
    Kasper S; Hale A; Azorin JM; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 2():II1-II14. PubMed ID: 10603070
    [No Abstract]   [Full Text] [Related]  

  • 20. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.